Researchers in Sweden sought to determine if use
of tumor necrosis factor inhibitor drugs to treat RA would result in a reduced risk
of acute coronary syndrome (commonly called ACS),
defined as a diagnosis
of a
heart attack or unstable angina (the worsening or increasing cardiac
symptoms)